This report from Life Science Intelligence provides the latest market data for the Global PTA Balloon Cathters and Vena Cava Filters Market. Information covered by this report includes:
· unit volumes & pricing forecast from 2019-2024
· analyses of the leading companies, and
· global market share analysis.
The global market for percutaneous transluminal angioplasty (PTA) balloon catheters and vena cava filters was valued at an estimated $1.1 billion in 2020 and is projected to increase at a CAGR (2020-2024) of 8.3%. Product segments covered by this report include peripheral vascular balloon catheters, introducers, guide catheters, and vena cava filters.
This report covers the impact of COVID-19 on the PTA balloon catheters and vena cava filters market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as Abbott, BD, Boston Scientific, Cook Medical, Cardinal Health, and others. The report provides insights into trends, drivers, and limiters of this market, as well as highlights potential opportunities.
The PTA balloon catheters and vena cava filters market was negatively impacted by the COVID-19 pandemic. The pandemic has affected elective surgical procedures markedly, as many non-critical procedures have been cancelled or postponed so that healthcare resources have been conserved for the treatment of COVID-19 and other critically ill patients.
BD, Cardinal Health, and Boston Scientific together account for approximately 65% of the market share in the global PTA balloon catheters and vena cava filters market. Abbott,
B. Braun, and Cook Medical are other key competitors with significant market share.